REVIEW article

Front. Cell. Neurosci.

Sec. Cellular Neuropathology

Volume 19 - 2025 | doi: 10.3389/fncel.2025.1588645

This article is part of the Research TopicRecent Advances in Mitochondrial Dysfunction and Therapeutics for Neurodegeneration and AgingView all 8 articles

Role of Mitochondrial Quality Control in Neurodegenerative Disease Progression 1

Provisionally accepted
Tingting  LiuTingting Liu1Weibo  SunWeibo Sun2Shuhao  GuoShuhao Guo1Zhiying  YuanZhiying Yuan1Minghang  ZhuMinghang Zhu1Jing  LuJing Lu1Tao  ChenTao Chen1Yuanyuan  QuYuanyuan Qu3Chuwen  FengChuwen Feng1Tiansong  YangTiansong Yang3*
  • 1Heilongjiang University of Chinese Medicine, Harbin, China
  • 2First Clinical College of Harbin Medical University, harbin, China
  • 3Department of Rehabilitation Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Jilin Province, China

The final, formatted version of the article will be published soon.

Neurodegenerative diseases are a diverse group of neurological disorders, in which abnormal mitochondrial function is closely associated with their development and progression. This has generated significant research interest in the field. The proper functioning of mitochondria relies on the dynamic regulation of the mitochondrial quality control system. Key processes such as mitochondrial biogenesis, mitophagy, and mitochondrial dynamics (division/fusion) are essential for maintaining this balance. These processes collectively govern mitochondrial function and homeostasis.Therefore, the mitochondrial quality control system plays a critical role in the onset and progression of neurodegenerative diseases. This article provides a concise overview of the molecular mechanisms involved in mitochondrial biogenesis, mitophagy, and mitochondrial dynamics, explores their interactions, and summarizes current research progress in understanding the mitochondrial quality control system in the context of neurodegenerative diseases.

Keywords: Mitochondrial quality control, Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis

Received: 06 Mar 2025; Accepted: 14 Apr 2025.

Copyright: © 2025 Liu, Sun, Guo, Yuan, Zhu, Lu, Chen, Qu, Feng and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tiansong Yang, Department of Rehabilitation Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Jilin Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.